Medicine and Dentistry
Peripheral Blood Mononuclear Cell
100%
Interferon Production
100%
Interferon
83%
Oral Cancer
83%
Cytokine
50%
Stimulation
50%
Inpatient
50%
Serum
33%
Neutralization
33%
Advanced Cancer
16%
In Vitro
16%
Interleukin 6
16%
Immunocompetent Cell
16%
Vasculotropin
16%
Cytotoxicity
16%
Malignant Neoplasm
16%
Interleukin 12
16%
Interleukin 2
16%
Immunotherapy
16%
Interleukin 4
16%
Anticarcinogen
16%
Interleukin 10
16%
Early Cancer
16%
Oral Cancer Cell Line
16%
Patient
16%
Culture
16%
Transforming Growth Factor
16%
Immunology and Microbiology
Peripheral Blood Mononuclear Cell
100%
Interferon Production
100%
Interferon Type I
83%
Cancer Cell
50%
Blood Level
33%
Normal Human
16%
Interleukin 6
16%
Interleukin 10
16%
Cytotoxicity
16%
Immunocompetent Cell
16%
Interleukin 12
16%
Interleukin 2
16%
Immunotherapy
16%
Interleukin 4
16%
Molecule
16%
Vasculotropin
16%
Immune Status
16%
Oral Cancer Cell Line
16%
Dose
16%
Transforming Growth Factor
16%
Neuroscience
Peripheral Blood Mononuclear Cell
100%
Interferon Production
100%
Interferon
83%
Interleukin 6
16%
In Vitro
16%
Cytotoxicity
16%
Interleukin 4
16%
Interleukin 2
16%
Interleukin 10
16%
Immunotherapy
16%
Interleukin 12
16%
Transforming Growth Factor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Interferon
83%
Mouth Cancer
83%
Cytokine
50%
Anticarcinogen
16%
Normal Human
16%
Interleukin 6
16%
Interleukin 4
16%
Interleukin 10
16%
Interleukin 12
16%
Vasculotropin
16%
Interleukin 2
16%
Malignant Neoplasm
16%
Immunotherapy
16%
Advanced Cancer
16%
Early Cancer
16%
Transforming Growth Factor
16%
Veterinary Science and Veterinary Medicine
Peripheral Blood Mononuclear Cell
100%
Cancer Cell
50%
Vascular Endothelial Growth Factor
16%
Transforming Growth Factor
16%